Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Monopar Therapeutics (MNPR) Operating Expenses: 2016-2019

Historic Operating Expenses for Monopar Therapeutics (MNPR) over the last 4 years, with Dec 2019 value amounting to $4.3 million.

  • Monopar Therapeutics' Operating Expenses rose 32.23% to $1.2 million in Q4 2019 from the same period last year, while for Dec 2019 it was $4.3 million, marking a year-over-year increase of 36.88%. This contributed to the annual value of $4.3 million for FY2019, which is 29.80% up from last year.
  • Latest data reveals that Monopar Therapeutics reported Operating Expenses of $4.3 million as of FY2019, which was up 29.80% from $3.3 million recorded in FY2018.
  • Over the past 5 years, Monopar Therapeutics' Operating Expenses peaked at $16.6 million during FY2017, and registered a low of $1.2 million during FY2016.
  • For the 3-year period, Monopar Therapeutics' Operating Expenses averaged around $8.1 million, with its median value being $4.3 million (2019).
  • Per our database at Business Quant, Monopar Therapeutics' Operating Expenses skyrocketed by 1,291.91% in 2017 and then crashed by 79.94% in 2018.
  • Monopar Therapeutics' Operating Expenses (Yearly) stood at $1.2 million in 2016, then soared by 1,291.91% to $16.6 million in 2017, then slumped by 79.94% to $3.3 million in 2018, then increased by 29.80% to $4.3 million in 2019.